The effect of cardiac resynchronization on morbidity and mortality in heart failure. JG Cleland JC Daubert E Erdmann N Freemantle D Gras L Kappenberger, et al. N Engl J Med 2005 352 1539 1549 10.1056/NEJMoa050496 15753115 (Pubitemid 40517094)
Cardiac resynchronization in chronic heart failure. WT Abraham WG Fisher AL Smith DB Delurgio AR Leon E Loh, et al. N Engl J Med 2002 346 1845 1853 10.1056/NEJMoa013168 12063368
Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. C Linde C Leclercq S Rex S Garrigue T Lavergne S Cazeau, et al. J Am Coll Cardiol 2002 40 111 118 10.1016/S0735-1097(02)01932-0 12103264
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. MR Bristow LA Saxon J Boehmer S Krueger DA Kass T De Marco, et al. N Engl J Med 2004 350 2140 2150 10.1056/NEJMoa032423 15152059
Effect of cardiac resynchronization therapy on functional mitral regurgitation in heart failure. P Lancellotti P Melon N Sakalihasan A Waleffe C Dubois M Bertholet, et al. Am J Cardiol 2004 94 1462 1465 10.1016/j.amjcard. 2004.07.154 15566929
Early and late effects of cardiac resynchronization therapy on exercise-induced mitral regurgitation: relationship with left ventricular dyssynchrony, remodelling and cardiopulmonary performance. J Madaric M Vanderheyden C Van Laethem K Verhamme A Feys M Goethals, et al. Eur Heart J 2007
A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy: insights from mechanical activation strain mapping. H Kanzaki R Bazaz D Schwartzman K Dohi LE Sade J Gorcsan III, J Am Coll Cardiol 2004 44 1619 1625 10.1016/j.jacc.2004.07.036 15489094
Time course of effects of cardiac resynchronization therapy in chronic heart failure: benefits in patients with preserved exercise capacity. MF Piepoli GQ Villani U Corra D Aschieri G Rusticali, Pacing Clin Electrophysiol 2008 31 701 708 10.1111/j.1540-8159.2008.01073.x 18507542
Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. RW Troughton CM Frampton TG Yandle EA Espiner MG Nicholls AM Richards, Lancet 2000 355 1126 1130 10.1016/S0140-6736(00)02060-2 10791374
Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy. DR Murdoch TA McDonagh J Byrne L Blue R Farmer JJ Morton, et al. Am Heart J 1999 138 1126 1132 10.1016/S0002-8703(99)70079-7 10577444
Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony. FM Fruhwald A Fahrleitner-Pammer R Berger F Leyva N Freemantle E Erdmann, et al. Eur Heart J 2007 28 1592 1597 10.1093/eurheartj/ehl505 17298973
B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. P de Groote J Dagorn B Soudan N Lamblin E McFadden C Bauters, J Am Coll Cardiol 2004 43 1584 1589 10.1016/j.jacc.2003.11.059 15120815
Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. WA Zoghbi M Enriquez-Sarano E Foster PA Grayburn CD Kraft RA Levine, et al. J Am Soc Echocardiogr 2003 16 777 802 10.1016/S0894-7317(03)00335-3 12835667
Intra-left ventricular electromechanical asynchrony. A new independent predictor of severe cardiac events in heart failure patients. H Bader S Garrigue S Lafitte S Reuter P Jais M Haissaguerre, et al. J Am Coll Cardiol 2004 43 248 256 10.1016/j.jacc.2003.08.038 14736445
Impact of contractile reserve on acute response to cardiac resynchronization therapy. M Moonen M Senechal B Cosyns P Melon E Nellessen L Pierard, et al. Cardiovasc Ultrasound 2008 6 65 19117517
Myocardial contractile reserve during exercise predicts left ventricular reverse remodelling after cardiac resynchronization therapy. P Lancellotti M Senechal M Moonen E Donal J Magne E Nellessen, et al. Eur J Echocardiogr 2009 10 663 8 10.1093/ejechocard/jep033 19351652
Identification of responders to cardiac resynchronization therapy by contractile reserve during stress echocardiography. Q Ciampi L Pratali R Citro M Piacenti B Villari E Picano, Eur J Heart Fail 2009 11 489 496 10.1093/eurjhf/hfp039 19324921
Decrease in plasma B-type natriuretic peptide early after initiation of cardiac resynchronization therapy predicts clinical improvement at 12 months. M Kubanek I Malek J Bytesnik P Fridl L Riedlbauchova L Karasova, et al. Eur J Heart Fail 2006 8 832 840 10.1016/j.ejheart.2006.02.006 16546444
Predictors of remodeling in the CRT era: influence of mitral regurgitation, BNP, and gender. TP Cappola MR Harsch M Jessup WT Abraham JB Young S Petersen-Stejskal, et al. J Card Fail 2006 12 182 188 10.1016/j.cardfail.2005.11.003 16624682
Suboptimal medical therapy in patients with systolic heart failure is associated with less improvement by cardiac resynchronization therapy. JW Fung JY Chan LC Kum HC Chan GW Yip Q Zhang, et al. Int J Cardiol 2007 115 214 219 10.1016/j.ijcard.2006.04.034 16797091
Prognostic value of brain natriuretic peptide in the management of patients receiving cardiac resynchronization therapy. MV Pitzalis M Iacoviello F Di Serio R Romito P Guida E De Tommasi, et al. Eur J Heart Fail 2006 8 509 514 10.1016/j.ejheart.2005.10.013 16503416
Usefulness of preimplantation B-type natriuretic peptide level for predicting response to cardiac resynchronization therapy. N Lellouche C De Diego DA Cesario M Vaseghi BN Horowitz A Mahajan, et al. Am J Cardiol 2007 99 242 246 10.1016/j.amjcard.2006.08.018 17223426
Electromechanical effects of cardiac resynchronization therapy during rest and stress in patients with heart failure. C Valzania F Gadler MJ Eriksson A Olsson G Boriani F Braunschweig, Eur J Heart Fail 2007 9 644 650 10.1016/j.ejheart.2007.01.009 17347041
Coronary and peripheral blood flow changes following biventricular pacing and their relation to heart failure improvement. P Flevari G Theodorakis I Paraskevaidis F Kolokathis A Kostopoulou D Leftheriotis, et al. Europace 2006 8 44 50 10.1093/europace/euj015 16627408
Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy. P Sogaard H Egeblad WY Kim HK Jensen AK Pedersen BO Kristensen, et al. J Am Coll Cardiol 2002 40 723 730 10.1016/S0735-1097(02)02010-7 12204503
Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. JA White R Yee X Yuan A Krahn A Skanes M Parker, et al. J Am Coll Cardiol 2006 48 1953 1960 10.1016/j.jacc.2006.07.046 17112984
Nuclear imaging in cardiac resynchronization therapy. MM Henneman EE van der Wall C Ypenburg GB Bleeker NR Van de Veire NA Marsan, et al. J Nucl Med 2007 48 2001 2010 10.2967/jnumed.107.040360 18056333
Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy. S Chalil PW Foley SA Muyhaldeen KC Patel ZR Yousef RE Smith, et al. Europace 2007 9 1031 1037 10.1093/europace/eum133 17933857
Myocardial contractile reserve predicts improvement in left ventricular function after cardiac resynchronization therapy. C Ypenburg A Sieders GB Bleeker ER Holman EE van der Wall MJ Schalij, et al. Am Heart J 2007 154 1160 1165 10.1016/j.ahj.2007.07.035 18035090
Importance of contractile reserve for CRT. P Lim C Bars L Mitchell-Heggs C Roiron N Elbaz B Hamdaoui, et al. Europace 2007 9 739 743 10.1093/europace/ eum117 17573360
Prospective validation of stress echocardiography as an identifier of cardiac resynchronization therapy responders. A Da Costa J Thevenin F Roche E Faure C Romeyer-Bouchard M Messier, et al. Heart Rhythm 2006 3 406 413 10.1016/j.hrthm.2005.12.017 16567286
Extent of viability to predict response to cardiac resynchronization therapy in ischemic heart failure patients. C Ypenburg MJ Schalij GB Bleeker P Steendijk E Boersma P Dibbets-Schneider, et al. J Nucl Med 2006 47 1565 1570 17015888
Presence of left ventricular contractile reserve, evaluated by means of dobutamine stress-echo test, is able to predict response to cardiac resynchronization therapy. B Tuccillo C Muto R Iengo M Accadia S Rumolo M Canciello, et al. J Interv Card Electrophysiol 2008 23 121 126 10.1007/s10840-008-9255-9 18587637
Only large reductions in concentrations of natriuretic peptides (BNP and NT-proBNP) are associated with improved outcome in ambulatory patients with chronic heart failure. WL Miller KA Hartman DE Grill JC Burnett Jr AS Jaffe, Clin Chem 2009 55 78 84 10.1373/clinchem.2008.108928 19028821
Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. CM Yu GB Bleeker JW Fung MJ Schalij Q Zhang EE van der Wall, et al. Circulation 2005 112 1580 1586 10.1161/CIRCULATIONAHA.105.538272 16144994
